Cysto Renew
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80047888
- Status
- Active licence
- Licence date
- 28 January 2014
- Revision date
- 19 February 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine dihydraté | 100 mg | Not calculated |
| Melissa officinalis Source : Feuille Extraction ratio : 5:1 Dry plant equivalent : 125 mg | 25 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 1,440,000 FCC CU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 40 mg | Not calculated |
| (S)-N5-Carbamoylornithine Source : Citrulline | 37.5 mg | Not calculated |
| Aloe vera Source : Gel de la feuille Extract : Matériel brut frais Extraction ratio : 200:1:? Dry plant equivalent : 5,000 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Cellulose, microcristalline, Stéarate de magnésium, Gélatine, Silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 2 Capsule | minimum: 2 Tous les jours ; maximum: 2 Tous les jours |
| Adultes | Not specified | minimum: 3 Capsule ; maximum: 3 Capsule | minimum: 2 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain proper muscle function. An antioxidant. L-Arginine is a non-essential amino acid that is involved in protein synthesis. Helps temporarily relieve symptoms of stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80047888
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging